Both CK-18 M65 and M30, along with the MACK-3 score, were the only biomarkers that had a significantly higher AUROC for fibrotic NASH compared to advanced or significant fibrosis (Fig. 1A). Here, KRT18 is linked to metabolic dysfunction-associated steatohepatitis.